NLRP3 inflammasome inactivation driven by miR-223-3p reduces tumor growth and increases anticancer immunity in breast cancer

MicroRNA-233-3p (miR-223-3p) is considered an important cancer-associated marker. The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome represents a novel potential target for the treatment of breast cancer. Therefore, it was hypothesized that miR-223-3p may affect tumor growth an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liping, Li, Hongzhi, Zang, Yuwei, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390045/
https://www.ncbi.nlm.nih.gov/pubmed/30747211
http://dx.doi.org/10.3892/mmr.2019.9889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390045/
https://www.ncbi.nlm.nih.gov/pubmed/30747211
http://dx.doi.org/10.3892/mmr.2019.9889

Ejemplares similares